Tag: cisplatininduced
Sensorion: first patient in SENS-401 Phase 2a proof-of-concept trial in cisplatin-induced ototoxicity
Through Arnaud Bives Published on 03/01/2023 at 07:41 (Boursier.com) — Sensorion enrolled the first patient in its Phase 2a proof-of-concept clinical trial…